Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004316HBVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS10030449HBVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS30000696HIVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS30008919HIVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS30076444HIVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS30063856HIVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS20021890HPVENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS44014700HTLV-1ENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS44016407HTLV-1ENSG00000113263.14protein_codingITKNoNo3702Q08881
TVIS44000962HTLV-1ENSG00000113263.14protein_codingITKNoNo3702Q08881
TCGA Plot Options
Drug Information
GeneITK
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0001341
UniProt IDQ08881
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830